key: cord-0915477-rtw66i4y
authors: Panchariya, Love; Khan, Wajahat Ali; Kuila, Shobhan; Sonkar, Kirtishila; Sahoo, Sibasis; Ghoshal, Archita; Kumar, Ankit; Verma, Dileep Kumar; Hasan, Abdul; Das, Shubhashis; Thakur, Jitendra K; Halder, Rajkumar; Sunil, Sujatha; Arockiasamy, Arulandu
title: Zinc2+ ion inhibits SARS-CoV-2 main protease and viral replication in vitro
date: 2021-07-13
journal: bioRxiv
DOI: 10.1101/2021.06.15.448551
sha: 7092ce686d843e5511bedc33e2562689d51e955b
doc_id: 915477
cord_uid: rtw66i4y

Zinc deficiency is linked to poor prognosis in COVID-19 patients while clinical trials with Zinc demonstrate better clinical outcome. The molecular target and mechanistic details of anti-coronaviral activity of Zinc remain obscure. We show that ionic Zinc not only inhibits SARS-CoV-2 main protease (Mpro) with nanomolar affinity, but also viral replication. We present the first crystal structure of Mpro-Zn2+ complex at 1.9 Å and provide the structural basis of viral replication inhibition. We show that Zn2+ coordinates with the catalytic dyad at the enzyme active site along with two previously unknown water molecules in a tetrahedral geometry to form a stable inhibited Mpro-Zn2+ complex. Further, natural ionophore quercetin increases the anti-viral potency of Zn2+. As the catalytic dyad is highly conserved across SARS-CoV, MERS-CoV and all variants of SARS-CoV-2, Zn2+ mediated inhibition of Mpro may have wider implications.

Abstract: 25 Zinc deficiency is linked to poor prognosis in COVID-19 patients while clinical trials with Zinc 26 demonstrate better clinical outcome. The molecular target and mechanistic details of anti-27 coronaviral activity of Zinc remain obscure. We show that ionic Zinc not only inhibits SARS- 28 CoV-2 main protease (Mpro) with nanomolar affinity, but also viral replication. We present the 29 first crystal structure of Mpro-Zn 2+ complex at 1.9 Å and provide the structural basis of viral 30 replication inhibition. We show that Zn 2+ coordinates with the catalytic dyad at the enzyme 31 active site along with two previously unknown water molecules in a tetrahedral geometry to form 32 a stable inhibited Mpro-Zn 2+ complex. Further, natural ionophore quercetin increases the anti- potential key molecular targets of Zinc. However, the structure of SARS-CoV-2 RDRP 15 47 suggests a structural role for Zinc rather than an inhibitory one. Notably, detailed kinetics and 48 mechanism of ionic Zinc targeting SARS-CoV-2 Mpro is lacking. 49 We first studied one on one binding kinetics of Zinc acetate with purified SARS-CoV-2 Mpro 50 using Surface Plasmon Resonance (SPR). Zinc binds to SARS-CoV-2 Mpro with an association 51 rate constant (ka) of 8,930±30 M -1 s -1 and the dissociation rate constant (kd) of 0.01755±10 s -1 , 52 and an equilibrium dissociation constant (KD) of 1.965E-06 M. (Fig. 1a) The half-life (t1/2=ln 53 [0.5]/kd) of Mpro-Zn 2+ complex is ~40s. We then assessed the inhibitory effects of Zn 2+ binding 54 on the proteolytic activity of SARS-COV-2 Mpro in the presence of Zinc acetate. We obtained 55 an IC50 value of 325.1 ± 5.1 nM with complete inhibition at 6.25 µM and above (Fig. 1b) . We 56 also tested Zinc glycinate and Zinc gluconate complexes, which are available as Zinc and 1b). Reversibility of Zn 2+ -mediated inhibition was tested by first inhibiting the enzyme with 60 500 nM Zinc acetate, and then initiating the reaction with a substrate peptide, followed by 61 addition of EDTA to regain the enzyme activity by chelating Zn 2+ ions. We find that Zinc 62 inhibition is completely reversible by EDTA (Supplementary Figure 1c) , suggesting that 63 inhibition by the metal ion is not because of oxidation of catalytic cysteine (Cys145).

To further understand the structural basis of SARS-CoV-2 Mpro inhibition by Zn 2+ ion, we 65 solved the crystal structure of the bound complex at 1.9 Å (Supplementary Table 2 ). The 66 asymmetric unit contains a dimer of Mpro in space group P212121 (Fig. 1c ). An unambiguous 67 electron density for Zn 2+ (Fig. 1d, e) shows that the metal ion is coordinated by the catalytic dyad 68 His41 and Cys145, which is absent in the control datasets collected for apo-enzyme crystals 69 grown in the same condition. Zn 2+ -bound complex shows a tetrahedral coordination geometry at 70 the Mpro active site by coordinating with two water molecules that are absent in the apo-enzyme 71 structure (Fig. 1c) . Distortion in the tetrahedral geometry observed is attributed to the presence 72 of heterogeneous atoms; sulphur (Cys145-SG) and nitrogen (His41-NE2) in the inhibited 73 complex. A 180⁰ flip of the imidazole ring of His41 brings NE2 closer to Zn 2+ with an inter-74 atomic distance of 1.94 Å to form a coordinate bond. The interatomic distance between catalytic 75 Cys145 and Zn 2+ is 2.36 Å consistent with observed bound complexes. Two structural water 76 molecules W1 and W2 (PDB: 7DK1; HETATM 5028 and 5031, respectively) coordinate Zn 2+ at 77 an inter-atomic distance of 2.23 Å and 1.98 Å, respectively, to satisfy the tetrahedral geometry 78 (Fig. 1c) . The coordination of Zn 2+ with the catalytic dyad is expected to prevent a nucleophilic 79 attack on the carbonyl moiety of the amide bond in polyprotein substrate. We hypothesize that 80 the two strongly coordinated water molecules impart stability to the Zn 2+ inhibited complex W1 and W2 remain bound to Zn 2+ throughout the simulation, and help maintain the tetrahedral 89 geometry observed in complex crystal structure (Fig. 1g ) 90 We further assessed the inhibitory potential of Zinc acetate, Zinc glycinate and Zinc gluconate glycinate. We observed that Zinc acetate treatment resulted in more than 50% reduction of viral 95 titre, as compared to the untreated infected cells (Fig. 2a) . Based on these results, we determined 96 the IC50 of Zinc acetate to be 3.227 µM (Fig 2b) . Surprisingly, Zinc glycinate and Zinc To test this, we mixed Zinc acetate with Quercetin at 1:2 molar ratio 18 at non-toxic 102 concentrations (Supplementary Figure 2) and tested the antiviral activity against SARS-CoV-2. 103 We observed >2-fold viral inhibition in the presence of Quercetin (Fig. 2c) . 104 Taken together, our data strongly suggest an inhibitory role for ionic Zinc 11 , wherein it inhibits The antiviral experiments were repeated at least twice, and each experiment included at least 165 three replicates. Statistical significance was determined using Student's t-test (n ≥ 2 biological 166 replicates). 

A new coronavirus associated with human respiratory disease in China

Covid-19: New coronavirus variant is identified in UK

Isolation and characterization of the new SARS-CoV-2 variant in travellers from 174 the United Kingdom to India: VUI-202012/01 of the B.1.1.7 lineage

COVID-19: Poor outcomes in patients with zinc deficiency

Low Zinc Levels at Admission Associates with Poor Clinical Outcomes in 182 SARS-CoV-2 Infection

Zinc sulfate in combination with a zinc ionophore may improve outcomes in 186 hospitalized COVID-19 patients

Among COVID-19 Patients: A Multi-Center Cohort Study. Res Sq

COVID-19 outpatients: early risk-stratified treatment with 192 zinc plus low-dose hydroxychloroquine and azithromycin: a retrospective case series study

Relationship between the architecture of zinc coordination 196 and zinc binding affinity in proteins--insights into zinc regulation

Inhibitory zinc sites in enzymes

Zinc coordination environments in proteins determine zinc functions

The Role of Zinc in Antiviral Immunity

Evaluation of metal-conjugated compounds as inhibitors of 3CL protease of SARS

Zn(2+) inhibits coronavirus and arterivirus RNA polymerase activity in vitro 210 and zinc ionophores block the replication of these viruses in cell culture

Mechanism of SARS-CoV-2 polymerase stalling by remdesivir

Effect of High-Dose Zinc and Ascorbic Acid Supplementation vs Usual Care on 216 Symptom Length and Reduction Among Ambulatory Patients With SARS-CoV-2 Infection: The 217 COVID A to Z Randomized Clinical Trial

Zinc ionophore activity of quercetin and epigallocatechin-gallate: 220 from Hepa 1-6 cells to a liposome model

Antioxidant Properties and UV-Protection Capacity

Structural basis of inhibition specificities of 3C and 3C-like proteases by zinc-225 coordinating and peptidomimetic compounds

Structural basis of mercury-and zinc-conjugated complexes as SARS-CoV 3C-like 229 protease inhibitors

X-ray screening identifies active site and allosteric inhibitors of SARS-CoV-2 232 main protease